Profil
Henrik Damkjær Simonsen currently works at Iconovo AB, as Chief Financial Officer from 2023.
Mr. Simonsen also formerly worked at Skandinaviska Enskilda Banken AB (Broker Denmark), as Analyst from 2004 to 2011, Nuevolution AB, as Chief Financial Officer, and SAGA Diagnostics AB, as Chief Financial officer.
Mr. Simonsen received his graduate degree from the University of Copenhagen.
Aktive Positionen von Henrik Simonsen
| Unternehmen | Position | Beginn |
|---|---|---|
| ICONOVO AB | Finanzdirektor/CFO | 01.04.2023 |
Ehemalige bekannte Positionen von Henrik Simonsen
| Unternehmen | Position | Ende |
|---|---|---|
Skandinaviska Enskilda Banken AB (Broker Denmark)
Skandinaviska Enskilda Banken AB (Broker Denmark) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.01.2011 |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Finanzdirektor/CFO | - |
| NUEVOLUTION AB (PUBL) | Finanzdirektor/CFO | - |
Ausbildung von Henrik Simonsen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skandinaviska Enskilda Banken AB (Broker Denmark)
Skandinaviska Enskilda Banken AB (Broker Denmark) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Nuevolution AB
Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Iconovo AB
Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Health Technology |
















